#USA #California #Class Action #Securities Fraud #Hims & Hers

Major Class Action Lawsuit Filed Against Hims & Hers Health, Inc.

On September 11, 2026, Kessler Topaz Meltzer & Check, LLP, a prominent national law firm specializing in securities litigation, announced the filing of a class action lawsuit against Hims & Hers Health, Inc. (NYSE: HIMS). This legal action is directed at investors who purchased HIMS securities between August 4, 2025, and July 29, 2026. The allegations underline critical concerns regarding the company’s privacy practices and the misrepresentation of its operational status.

Background of the Allegations

The suit accuses Hims of securities fraud through significantly misleading statements and omissions related to the company’s privacy and operational protocols. According to the complaint, key claims include:
1. Hims allegedly shared sensitive health information of its consumers with third-party advertising platforms.
2. The company reportedly charged consumers for prescriptions immediately upon submitting an intake form, contrary to their claims that they would have consultations to determine appropriate treatments.
3. These actions exposed Hims to potential regulatory penalties, contradicting positive assertions made by its executives about the company's standing and future prospects.

The Impact of FTC Action

The situation escalated dramatically on July 29, 2026, when the Federal Trade Commission (FTC) filed its own lawsuit against Hims. The FTC accused the company of engaging in "deceptive and unlawful privacy practices," including the illicit sharing of customers’ medical details with advertisers such as Snap and Meta Platforms. This news prompted a drastic decline in HIMS’s stock price, dropping by 14.73%, equating to a loss of $4.32 per share, which closed at $25.00 on the same day.

What Investors Should Know

Investors affected by the allegations and who have suffered losses on their investments are urged to take action. The deadline to file for lead plaintiff status is November 2, 2026. Potential lead plaintiffs will represent the interests of the class throughout the litigation process.

Kessler Topaz Meltzer & Check encourages affected investors to reach out for legal assistance regarding their rights and options for recovery. They offer a free case evaluation, ensuring that representation is on a contingency basis, meaning no fees unless the case is successful.

Next Steps for Investors

Affected individuals can contact Kessler Topaz Meltzer & Check, LLP for further details on how to navigate this legal landscape. Investors are encouraged to take swift action to secure their standing in the potentially impactful litigation. They can explore their rights by visiting the firm's official website or contact attorney Jonathan Naji directly.

Conclusion

The allegations against Hims & Hers Health, Inc. serve as a critical reminder of the importance of transparency in business practices, particularly in the health sector. Investors are advised to remain vigilant about such developments, as their financial interests hang in the balance amid the ongoing legal proceedings. Keeping abreast of the lawsuit’s progress will be crucial for those affected as the case unfolds in the courts.